Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back

A. Avan; P. Pacetti; M. Reni; M. Milella; E. Vasile; A. Mambrini; V. Vaccaro; S. Caponi; S. Cereda; G.J. Peters; M. Cantore; E. Giovannetti

doi:https://doi.org/10.1002/ijc.28078

Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back

A. Avan, P. Pacetti, M. Reni, M. Milella, E. Vasile, A. Mambrini, V. Vaccaro, S. Caponi, S. Cereda, G.J. Peters, M. Cantore, E. Giovannetti

Medical oncology laboratory (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

25 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1016-1022
Journal	International journal of cancer
Volume	133
Issue number	4
DOIs	https://doi.org/10.1002/ijc.28078
Publication status	Published - 2013

Access to Document

https://doi.org/10.1002/ijc.28078

Cite this

Avan, A., Pacetti, P., Reni, M., Milella, M., Vasile, E., Mambrini, A., Vaccaro, V., Caponi, S., Cereda, S., Peters, G. J., Cantore, M., & Giovannetti, E. (2013). Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back. International journal of cancer, 133(4), 1016-1022. https://doi.org/10.1002/ijc.28078

@article{e2b0055808194fb9808030bb3882f53e,

title = "Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back",

author = "A. Avan and P. Pacetti and M. Reni and M. Milella and E. Vasile and A. Mambrini and V. Vaccaro and S. Caponi and S. Cereda and G.J. Peters and M. Cantore and E. Giovannetti",

year = "2013",

doi = "https://doi.org/10.1002/ijc.28078",

language = "Undefined/Unknown",

volume = "133",

pages = "1016--1022",

journal = "International journal of cancer",

issn = "0020-7136",

publisher = "International Union Against Cancer",

number = "4",

}

Avan, A, Pacetti, P, Reni, M, Milella, M, Vasile, E, Mambrini, A, Vaccaro, V, Caponi, S, Cereda, S, Peters, GJ, Cantore, M & Giovannetti, E 2013, 'Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back', International journal of cancer, vol. 133, no. 4, pp. 1016-1022. https://doi.org/10.1002/ijc.28078

TY - JOUR

T1 - Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back

AU - Avan, A.

AU - Pacetti, P.

AU - Reni, M.

AU - Milella, M.

AU - Vasile, E.

AU - Mambrini, A.

AU - Vaccaro, V.

AU - Caponi, S.

AU - Cereda, S.

AU - Peters, G.J.

AU - Cantore, M.

AU - Giovannetti, E.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.1002/ijc.28078

DO - https://doi.org/10.1002/ijc.28078

M3 - Article

C2 - 23390054

SN - 0020-7136

VL - 133

SP - 1016

EP - 1022

JO - International journal of cancer

JF - International journal of cancer

IS - 4

ER -